MYCN and neoplasm: This pronounced advantage in mortality and DALYs among males may be attributed to a combination of genetic predispositions, such as MYCN amplification, physiological factors like androgen influence on tumor microenvironments, and socio-cultural factors including disparities in healthcare-seeking behaviors (15, 16).